Syndecan-1 Expression Is Increased in the Aortic Wall of Patients with Type 2 Diabetes but Is Unrelated to Elevated Fasting Plasma Glucagon-Like Peptide-1

A reduced prevalence of a thoracic aortic aneurysm (thoracic AA) is observed in type 2 diabetes (T2D). Glucagon-like peptide-1 (GLP-1)/GLP-1-based anti-diabetic therapy has indicated protective effects in thoracic AA and regulates the processes controlling the vascular tissue expression of Syndecan-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ntika, Stelia, Tracy, Linda M., Franco-Cereceda, Anders, Björck, Hanna M., Krizhanovskii, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233803/
https://www.ncbi.nlm.nih.gov/pubmed/34203009
http://dx.doi.org/10.3390/biomedicines9060697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233803/
https://www.ncbi.nlm.nih.gov/pubmed/34203009
http://dx.doi.org/10.3390/biomedicines9060697

Ejemplares similares